Please login to the form below

Not currently logged in
Email:
Password:

Alzheimer

This page shows the latest Alzheimer news and features for those working in and with pharma, biotech and healthcare.

Tox trouble stalls Sosei/Allergan Alzheimer’s drug

Tox trouble stalls Sosei/Allergan Alzheimer’s drug

Tox trouble stalls Sosei/Allergan Alzheimer’ s drug. Surprise findings from primate studies. ... of muscarinic agonists for the treatment of major neurological disorders, including Alzheimer’s disease.

Latest news

More from news
Approximately 101 fully matching, plus 422 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 24 partially matching documents found.

Latest from PMHub

  • Alzheimer’s disease: reviewing the immediate treatment horizon

    Alzheimer’ s disease: reviewing the immediate treatment horizon. Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to ... A recent article by BLH Consultant David Cooney

  • Alzheimer's: the numbers we cannot forget

    I would love to be talking about our latest thinking around launching new therapies in Alzheimer’ s disease (AD) but I can’ t – no one can. ... Among the worst attrition rates in the industry. 99.6% of all trials in Alzheimer’ s disease (AD)

  • Forecasting in Forgotten Markets

    This charitable fund represents collaboration between the Department of Health, Alzheimer’ s Research UK () and a number of Big Pharma companies.

  • Alzheimer's and Brain Awareness Month

    June 2017 is Alzheimer’ s and Brain Awareness Month, which aims to raise awareness about Alzheimer’ s disease (AD) and other types of dementia1. ... 5. Alzheimer's hopes dashed as Lilly gives up on amyloid drug solanezumab.

  • Pragmatic Digital Health

    This can be at an individual level where apps are already at a developmental stage of being able to detect early signs of dementia and Alzheimer’ s through to the huge

More from PMHub
Approximately 4 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics